FDA's liquid biopsy approval is a milestone for Guardant Health AMEA: CEO

Simranjit Singh, CEO of Guardant Health AMEA, talks to "Squawk Box Asia" about obtaining the U.S. Food and Drug Administration's first liquid biopsy approval that can help in cancer detection and treatment.